Gary Sender is the retired Chief Financial Officer of Nabriva Therapeutics. He was in this role from 2016 until 2021. Prior to joining Nabriva, he served as CFO and executive vice president at Synergy Pharmaceuticals from 2015 to 2016. From 2009 until 2015, Mr. Sender served as senior vice president, finance, at Shire, supporting its specialty pharmaceuticals business and subsequently its global commercial businesses. Prior to joining Shire, Mr. Sender served as the founding CFO of Tengion from August 2004 to July 2009. Mr. Sender also spent 15 years in several leadership roles within Merck. Mr. Sender received his B.S. from Boston University and an MBA from Carnegie Mellon University.